Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibiotics
antibiotics
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback
Xconomy
Wed, 02/14/18 - 11:43 am
FDA
Tetraphase Pharmaceuticals
clinical trials
Eravacycline
antibiotics
Merck spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D
Endpoints
Mon, 01/29/18 - 10:30 am
Merck
antibiotics
R&D
Prokaryotics
Big Pharma invests in research for new antibiotics ($2bn)
GoinPharma
Sun, 01/21/18 - 09:05 pm
Big Pharma
R&D
antibiotics
Aradigm crashes after FDA panel votes down antibiotic
Fierce Biotech
Sat, 01/13/18 - 10:55 pm
Aradigm
FDA
advisory panels
antibiotics
Linhaliq
Bayer’s antibiotic drug-device combo fails in late-stage trial
Drug Delivery Business News
Mon, 11/27/17 - 11:38 pm
Bayer
drug-device combos
antibiotics
Amikacin
pneumonia
New antibiotic therapies: what future?
GoinPharma
Mon, 10/23/17 - 10:00 pm
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics
Endpoints
Mon, 10/16/17 - 09:43 am
Roche
Warp Drive Bio
antibiotics
R&D
Shooting for PhIII, Spero tees up a new lead antibiotic in-licensed cheap as it lines up $86M IPO
Endpoints
Wed, 10/11/17 - 10:00 am
Spero
antibiotics
clinical trials
Orapenem
SPR994
Motif delivers more strong data on its antibiotic
Biopharma Dive
Thu, 10/5/17 - 06:07 pm
Motif Biosciences
antibiotics
Iclaprim
skin infections
WHO raises alarm on lack of new antibiotics
GoInPharma
Fri, 09/22/17 - 09:09 am
WHO
antibiotics
drug development
Nabriva shares leap higher on antibiotic trial success
BioPharma Dive
Tue, 09/19/17 - 08:45 am
Nabriva Therapeutics
antibiotics
clinical trials
lefamulin
Patients Not Always Informed of Study's Purpose in Noninferiority Trials
RAPS.org
Thu, 08/24/17 - 05:12 pm
patients
noninferiority trials
antibiotics
clinical trials
GSK puts old antibiotics and UK Horlicks business on the block
Yahoo/Reuters
Wed, 07/19/17 - 09:34 am
GSK
antibiotics
MaxiNutrition
M&A
Paratek goes 3-for-3 in PhIII, but antibiotic stumbles on side effect profile
Endpoints
Tue, 07/18/17 - 09:21 am
Paratek
antibiotics
clinical trials
side effects
omadacycline
People Are Not Petri Dishes--A New Study Shows Why Antibiotics Fail
Forbes
Mon, 07/3/17 - 09:48 am
antibiotics
Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Endpoints
Mon, 06/19/17 - 11:35 pm
Melinta Therapeutics
FDA
antibiotics
delafloxacin
Baxdela
In the hunt for new antibiotics, scientists hit pay dirt
Washington Post, DC
Sat, 06/17/17 - 07:14 pm
antibiotics
drug development
R&D
Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
JNJ
Actelion
clinical trials
M&A
antibiotics
cadazolid
Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic
Fierce Biotech
Fri, 05/19/17 - 10:19 am
Iterum
antibiotics
Pfizer
clinical trials
sulopenem
FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!
FDA Law Blog
Mon, 05/8/17 - 11:32 am
FDA
generics
Zithromax
exclusivity
Pfizer
Lupin
antibiotics
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »